KMT5A and Miyoshi myopathy: Consistent with these results, SETD8 mRNA levels were significantly increased in patients harboring Chr1q21 gain (Additional files 2 and 3: Figure S1B) or presenting a high gene expression-based proliferation index (GPI) (Additional files 2 and 3: Figure S1C), molecular features being associated with a poor outcome in MM patients.